Wells Fargo says Live Nation is a buy ahead of Ticketmaster’s antitrust trial — $204 target
Wells Fargo initiated coverage of Live Nation with an “Overweight” rating and a $204 price target. The move comes as Live Nation seeks to delay a federal antitrust trial over Ticketmaster, set to begin March 2. TD Cowen raised its price target to $177 and maintained a Buy rating. U.S. District Judge Arun Subramanian signaled he is unlikely to grant a trial delay.